S1PR3: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
== S1PR3 == | {{Infobox protein | ||
| name = Sphingosine-1-phosphate receptor 3 | |||
| image = | |||
| caption = | |||
| width = | |||
| HGNCid = 10631 | |||
| symbol = S1PR3 | |||
| alt_symbols = EDG-3 | |||
| EntrezGene = 1903 | |||
| OMIM = 601974 | |||
| RefSeq = NM_005226 | |||
| UniProt = Q99500 | |||
| PDB = | |||
| ECnumber = | |||
| chromosomal_location = 9q22.1 | |||
}} | |||
'''Sphingosine-1-phosphate receptor 3''' ('''S1PR3''') is a [[G protein-coupled receptor]] that binds the [[bioactive lipid]] [[sphingosine-1-phosphate]] (S1P). It is part of the [[sphingosine-1-phosphate receptor]] family, which plays a crucial role in various physiological processes. | |||
==Structure== | |||
S1PR3 is a member of the [[G protein-coupled receptor]] (GPCR) superfamily, characterized by seven transmembrane domains. The receptor is encoded by the '''S1PR3''' gene located on chromosome 9q22.1. The protein structure allows it to interact with [[sphingosine-1-phosphate]], a signaling molecule involved in numerous cellular functions. | |||
==Function== | |||
S1PR3 is involved in the regulation of several physiological processes, including: | |||
* [[Vascular development]] and [[angiogenesis]] | |||
* [[Immune cell trafficking]] | |||
* [[Cardiovascular function]] | |||
* [[Inflammatory response]] | |||
The | The receptor mediates its effects through coupling with different [[G proteins]], leading to the activation of various downstream signaling pathways. | ||
==Expression== | |||
S1PR3 is expressed in a variety of tissues, including the [[endothelial cells]] of blood vessels, [[smooth muscle cells]], and [[immune cells]]. Its expression pattern suggests a role in both vascular and immune system functions. | |||
==Clinical Significance== | |||
Alterations in S1PR3 signaling have been implicated in several pathological conditions, such as: | |||
* [[Atherosclerosis]] | |||
* [[Hypertension]] | |||
* [[Autoimmune diseases]] | |||
* [[Cancer]] | |||
Research is ongoing to develop therapeutic agents targeting S1PR3 for the treatment of these conditions. | |||
== | ==See Also== | ||
* [[Sphingosine-1-phosphate receptor]] | |||
* [[G protein-coupled receptor]] | |||
* [[Bioactive lipid]] | |||
==External Links== | |||
* [https://www.wikimd.com/wiki/S1PR3 S1PR3 on WikiMD] | |||
* [https://www.ncbi.nlm.nih.gov/gene/1903 S1PR3 Gene - NCBI] | |||
{{G protein-coupled receptors}} | |||
{{Sphingolipids}} | |||
[[Category:Receptors]] | |||
[[Category:G protein-coupled receptors]] | [[Category:G protein-coupled receptors]] | ||
[[Category: | [[Category:Human proteins]] | ||
[[Category: | [[Category:Chromosome 9 genes]] | ||
Latest revision as of 12:40, 31 December 2024
Sphingosine-1-phosphate receptor 3 (S1PR3) is a G protein-coupled receptor that binds the bioactive lipid sphingosine-1-phosphate (S1P). It is part of the sphingosine-1-phosphate receptor family, which plays a crucial role in various physiological processes.
Structure[edit]
S1PR3 is a member of the G protein-coupled receptor (GPCR) superfamily, characterized by seven transmembrane domains. The receptor is encoded by the S1PR3 gene located on chromosome 9q22.1. The protein structure allows it to interact with sphingosine-1-phosphate, a signaling molecule involved in numerous cellular functions.
Function[edit]
S1PR3 is involved in the regulation of several physiological processes, including:
- Vascular development and angiogenesis
- Immune cell trafficking
- Cardiovascular function
- Inflammatory response
The receptor mediates its effects through coupling with different G proteins, leading to the activation of various downstream signaling pathways.
Expression[edit]
S1PR3 is expressed in a variety of tissues, including the endothelial cells of blood vessels, smooth muscle cells, and immune cells. Its expression pattern suggests a role in both vascular and immune system functions.
Clinical Significance[edit]
Alterations in S1PR3 signaling have been implicated in several pathological conditions, such as:
Research is ongoing to develop therapeutic agents targeting S1PR3 for the treatment of these conditions.
See Also[edit]
External Links[edit]
| Glycoconjugates, lipids, and glycolipids: sphingolipids and glycosphingolipids, and metabolic intermediates | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|